Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS: FRTX · Delayed Price · USD
0.910
+0.003 (0.28%)
Apr 18, 2024, 3:49 PM EDT - Market closed
Fresh Tracks Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.01 | 6.94 | 0.4 | 1.82 | 7.92 | 1.62 | 13.82 | 14.53 | 20.95 | 15.22 | Upgrade
|
| Revenue Growth (YoY) | 15.31% | 1618.56% | -77.83% | -76.99% | 388.10% | -88.26% | -4.90% | -30.64% | 37.67% | 97.16% | Upgrade
|
| Cost of Revenue | 0 | 14.04 | 28.23 | 11.22 | 20.21 | 1.44 | 6.48 | 6.29 | 10.93 | 10.82 | Upgrade
|
| Gross Profit | 8.01 | -7.1 | -27.83 | -9.39 | -12.3 | 0.19 | 7.34 | 8.24 | 10.02 | 4.39 | Upgrade
|
| Selling, General & Admin | 11.18 | 14.43 | 12.42 | 11.58 | 12.17 | 8.94 | 12.81 | 13.35 | 19.29 | 20.38 | Upgrade
|
| Research & Development | 3.18 | 14.04 | 28.23 | 11.22 | 20.21 | 12.33 | 14.39 | 10.36 | 11.06 | 11.47 | Upgrade
|
| Other Operating Expenses | 0.67 | 0.44 | 0.84 | 0 | 0 | -1.44 | -6.48 | -6.29 | -10.93 | -10.82 | Upgrade
|
| Operating Expenses | 14.37 | 28.48 | 40.65 | 22.8 | 32.39 | 21.27 | 27.21 | 23.71 | 30.35 | 31.84 | Upgrade
|
| Operating Income | -6.36 | -21.53 | -40.24 | -20.98 | -24.47 | -19.65 | -13.39 | -9.18 | -9.4 | -16.63 | Upgrade
|
| Interest Income | 0 | 0.01 | 0.07 | 0.06 | 1.94 | 0.06 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.01 | 0.01 | 0.07 | 0 | 2.1 | 1.09 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Expense / Income | -1.35 | -0.43 | -0.77 | - | -0.75 | -8.9 | 0.79 | 1.12 | - | 1.66 | Upgrade
|
| Pretax Income | -5.69 | -21.1 | -39.47 | -20.91 | -23.88 | -16.25 | -12.96 | -8.97 | -9.24 | -16.49 | Upgrade
|
| Income Tax | 0.68 | -0.44 | 0.05 | -0.01 | 2.07 | 4.48 | -1.22 | -1.32 | -0.17 | -1.8 | Upgrade
|
| Net Income | -5.69 | -20.66 | -39.52 | -20.9 | -25.95 | -16.25 | -12.96 | -8.97 | -9.24 | -16.49 | Upgrade
|
| Shares Outstanding (Basic) | - | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | - | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change | - | 57.33% | 227.63% | 710.92% | -3.12% | 69.47% | 28.64% | 9.20% | 3.33% | 2.24% | Upgrade
|
| EPS (Basic) | - | -7.36 | -22.14 | -38.37 | -386.21 | -234.41 | -316.76 | -282.12 | -317.17 | -585.11 | Upgrade
|
| EPS (Diluted) | - | -7.36 | -22.14 | -38.37 | -386.21 | -234.41 | -316.76 | -282.12 | -317.17 | -585.11 | Upgrade
|
| Free Cash Flow | -4.34 | -19.38 | -36.18 | -20.06 | -35.99 | 3.96 | -8.68 | -8.64 | -7.07 | -10.16 | Upgrade
|
| Free Cash Flow Per Share | - | -6.90 | -20.27 | -36.82 | -535.71 | 57.04 | -212.18 | -271.74 | -242.84 | -360.46 | Upgrade
|
| Gross Margin | 100.00% | -102.26% | -6887.87% | -515.59% | -155.32% | 11.47% | 53.12% | 56.71% | 47.84% | 28.87% | Upgrade
|
| Operating Margin | -79.44% | -310.15% | -9961.39% | -1151.26% | -309.06% | -1211.22% | -96.87% | -63.15% | -44.89% | -109.26% | Upgrade
|
| Profit Margin | -71.12% | -297.58% | -9782.43% | -1147.26% | -327.71% | -1002.10% | -93.78% | -61.75% | -44.10% | -108.38% | Upgrade
|
| Free Cash Flow Margin | -54.25% | -279.16% | -8956.44% | -1100.82% | -454.57% | 243.83% | -62.82% | -59.48% | -33.76% | -66.77% | Upgrade
|
| EBITDA | -5.65 | -21.09 | -40.24 | -20.98 | -24.47 | -23.04 | -13.81 | -9.38 | -8.41 | -16.76 | Upgrade
|
| EBITDA Margin | -70.55% | -303.80% | -9961.39% | -1151.26% | -309.06% | -1420.35% | -99.95% | -64.56% | -40.15% | -110.14% | Upgrade
|
| Depreciation & Amortization | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | 0.05 | 0.79 | 1.12 | 1.16 | 1.66 | Upgrade
|
| EBIT | -5.69 | -21.12 | -40.27 | -20.99 | -24.5 | -23.09 | -14.61 | -10.5 | -9.57 | -18.42 | Upgrade
|
| EBIT Margin | -71.06% | -304.23% | -9966.83% | -1151.81% | -309.41% | -1423.37% | -105.69% | -72.25% | -45.68% | -121.07% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.